David Gelbmann
Podiatrist · Chicago, ILNPI 1053609248
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,287 of the $7,924 with a category attached, or 79.3%. 20 manufacturers reported payments, led by Stryker at 52.8% of the total. Reporting peaked in 2024 at $2,987 and has fallen 70.2% since, to $891 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $77.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Angiodynamics, Inc.$1K
- Treace Medical Concepts, Inc.$615
- Cardiovascular Systems Inc.$297
- Organogenesis Inc.$276
- Smith+Nephew$262
- plus $1K from 14 others
What the payments were for
- Travel & lodging$1,45118%
- Food & beverage$6,28779%
- Education$1872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 38 | $4,187 |
| Angiodynamics, Inc. | 10 | $1,186 |
| Treace Medical Concepts, Inc. | 5 | $615 |
| Cardiovascular Systems Inc. | 3 | $297 |
| Organogenesis Inc. | 7 | $276 |
| Smith+Nephew | 11 | $262 |
| Amgen(2 entities) | 4 | $174 |
| Johnson & Johnson(2 entities) | 2 | $146 |
| Abbott | 2 | $144 |
| Orthofix Medical, Inc. | 3 | $130 |
| Fusion Orthopedics USA, LLC | 1 | $107 |
| Paragon 28, Inc. | 4 | $102 |
| ETS Wound Care LLC | 4 | $71 |
| Urgo Medical North America, LLC | 1 | $49 |
| Encore Medical, LP | 1 | $47 |
| Integra Lifesciences Corporation | 1 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Medshape, Inc. | 1 | $32 |
| Bioventus LLC | 1 | $20 |
| Next Science LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Viaflow$1,655
- Auryon Laser System 100-120 Vac$920
- PROstep$765
- PROSTEP MICA$558
- Lapiplasty System$501
- Diamondback Peripheral$405
- AUGMENT INJECTABLE$295
- CITREFIX$174
- Actishield$174
- INBONE$169
- ORTHOLOC 2 LAPIFUSE$152
- KRYSTEXXA$128
- PuraPly$116
- XARELTO$110
How this compares
$7,924 in reported general payments places this provider in the 90th percentile of 409 podiatrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 32 | $16,712 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $2,443 |
| Ammonium Lactate | 83 | $1,817 |
| Silver Sulfadiazine | 17 | $883 |
| Ketoconazole | 44 | $765 |
| Gentamicin Sulfate | 13 | $725 |
| Celecoxib | 15 | $232 |
| Ibuprofen | 23 | $211 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $133 |
| Mupirocin | 19 | $130 |
| Gabapentin | 12 | $112 |
| Triamcinolone Acetonide | 13 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $262 | $16,71232 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 409 podiatrist providers in Illinois.
Other podiatrist in Chicago
- Nathaniel GeorgeChicago$19K
- Walter JacobsenChicago$10K
- Leonid BlyuminChicago$6K
- Donna HayesChicago$6K
- Raymond Montoya IiChicago$6K
- Jondelle JenkinsChicago$6K
- Darla ThomasChicago$6K
- Carlos SmithChicago$6K
- Lisa Horn StinsonChicago$5K
- Ivan VelaChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.